Phmurph, I'm suggesting they license Cavatak for one of the cancer types (eg. bladder) at $200m. Imagine the return on separate licences for (how many cancer types are there again?)
But this is just my daydream. No one else has to buy into it!
VLA Price at posting:
65.5¢ Sentiment: Buy Disclosure: Held